Amneal Pharmaceuticals Reaps $2.5M in Kentucky Incentives
05/11/2010
"In addition to compelling economic incentives, we recognized that the superb quality and dedication of Glasgow's work force is a key factor in Amneal's reputation for service excellence, so the decision to stay and expand operations in Kentucky was an easy one," said Jim Luce, Amneal executive vice president of sales and marketing.
The Kentucky Economic Development Finance Authority has pre-approved Amneal for tax incentives up to $2.5 million through the Kentucky Business Investment program.
Amneal plans to use the funds to consolidate distribution logistics and sales in a 115,000-square-foot Glasgow facility. It will combine distribution that currently exists in Long Island, New York and Fountain Run, Kentucky. The company develops, manufactures, and distributes generic pharmaceuticals. It is the tenth largest supplier of generic drugs in the country in terms of prescriptions dispensed.
Project Announcements
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
First Quality Home Care Products Plans Archbold, Ohio, Production Facility
03/08/2026
PPG Expands Delaware, Ohio, Manufacturing Operations
03/08/2026
J.M. Smucker Company Expands Topeka, Kansas, Operations
03/05/2026
Novartis Gene Therapies Plans Denton, Texas, Operations
03/04/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025